🍽🦠 PubMed Studies Citing Bacteria Shifts for Bifidobacterium animalis {B. animalis} - Bifidobacterium lemurum

Citations are updated once a week. Recently added citations may not appear.

13 Citations Found, Full List Requires Login Summary Publisher Link Html Article Download Article Why do I only have some/no links buttons showing?
πŸ““ - Direct Citation   |   πŸ‘ͺ - Infer Parent  |   πŸ‘Ά - Infer Child |   βš—οΈ - Inferred from bacteria association
For Samples: 😁 - Shifts in right direction   |   😒 - Shifts in wrong direction
Context Citation
Bifidobacterium animalis {B. animalis} - Bifidobacterium lemurum    👶 Effects of Bifidobacterium lactis Bb12 supplementation on intestinal microbiota of preterm infants: a double-blind, placebo-controlled, randomized study.
Journal of clinical microbiology (J Clin Microbiol ) Vol: 44 Issue 11 Pages: 4025-31
Pub: 2006 Nov Epub: 2006 Sep 13 Authors Mohan R , Koebnick C , Schildt J , Schmidt S , Mueller M , Possner M , Radke M , Blaut M ,
Html Article Publication
Bifidobacterium animalis {B. animalis} - Bifidobacterium lemurum    👶 The Effect of Bifidobacterium animalis subsp. lactis MN-Gup on Glucose Metabolism, Gut Microbiota, and Their Metabolites in Type 2 Diabetic Mice.
Nutrients (Nutrients ) Vol: 16 Issue 11 Pages:
Pub: 2024 May 29 Epub: 2024 May 29 Authors Zhang C , Fang B , Zhang N , Zhang Q , Niu T , Zhao L , Sun E , Wang J , Xiao R , He J , Li S , Chen J , Guo J , Xiong W , Wang R ,
Html Article Publication
Bifidobacterium animalis {B. animalis} - Bifidobacterium lemurum    👶 Therapeutic Evaluation of Bifidobacterium animalis subsp. lactis MH-02 as an Adjunctive Treatment in Patients with Reflux Esophagitis: A Randomized, Double-Blind, Placebo-Controlled Trial.
Nutrients (Nutrients ) Vol: 16 Issue 3 Pages:
Pub: 2024 Jan 24 Epub: 2024 Jan 24 Authors Gan L , Wang Y , Huang S , Zheng L , Feng Q , Liu H , Liu P , Zhang K , Chen T , Fang N ,
Html Article Publication
Bifidobacterium animalis {B. animalis} - Bifidobacterium lemurum    👶 Bifidobacterium animalis subsp. lactis F1-7 Alleviates Lipid Accumulation in Atherosclerotic Mice via Modulating Bile Acid Metabolites to Downregulate Intestinal FXR.
Journal of agricultural and food chemistry (J Agric Food Chem ) Vol: 72 Issue 5 Pages: 2585-2597
Pub: 2024 Feb 7 Epub: 2024 Jan 29 Authors Liang X , Zheng X , Wang P , Zhang H , Ma Y , Liang H , Zhang Z ,
Publication
Bifidobacterium animalis {B. animalis} - Bifidobacterium lemurum    👶 Microbiological effects of consuming a synbiotic containing Bifidobacterium bifidum, Bifidobacterium lactis, and oligofructose in elderly persons, determined by real-time polymerase chain reaction and counting of viable bacteria.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (Clin Infect Dis ) Vol: 40 Issue 1 Pages: 28-37
Pub: 2005 Jan 1 Epub: 2004 Dec 6 Authors Bartosch S , Woodmansey EJ , Paterson JC , McMurdo ME , Macfarlane GT ,
Publication

BOOM

All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.

Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.


The awesome web hosting site that we use. Try it if you need to host (or unhappy with current provider)